briefs due today-- attached | CORT Message Board Posts


Corcept Therapeutics Inc

  CORT website

CORT   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  4512 of 4635  at  11/17/2023 11:20:29 AM  by

i760


 In response to msg 4511 by  ifscheiber
view thread

Re: briefs due today-- attached

 Ifscheiber wrote:  "why not leave out the comments on titration, then they can go to market without violating the patent, ... ahh wait, then FDA would not allow their product to be sold"
 
That is the quick reason why Corcept has said all along that they are confident that they will prevail.  Teva's bet was to invalidate the patent via the IPR and then via appealing the IPR decision.  They lost that so there will be no at-risk launch. The rest of the process at district court has been legal maneuvering and the back and forth in hopes that somehow, they can salvage something. 
 
Corcept has been unwilling to settle so the process (to just makes things go away) will go on and on until the beyond Rela readout.  If that is positive (shows that it is as good on efficacy as Mife) the game over.  



     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 2  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
4513 Re: briefs due today-- attached ShawnTSB 0 11/17/2023 1:22:33 PM




Financial Market Data provided by
.
Loading...